Hidden Signals in Placental Biochemistry: Papp-A Mom as an Early Indicator of Trisomy 21
References
- Mazer Zumaeta A, Wright A, Syngelaki A et al. Screening for trisomies at 11-13 weeks’ gestation: use of PAPP-A, PIGF or both. Prenat Diagn. 2020;40(11):1421-9.
- Kagan KO, Wright D, Spencer K et al. First-trimester screening for trisomy 21 by free p-hCG and PAPP-A: impact of maternal and pregnancy characteristics. Ultrasound Obstet Gynecol. 2008;31(5):493-502. doi:10.1002/uog.5332
- Zhang Y, Li l-l, Wang Q et al. Chinese cohort evaluation of PAPP-A S0.5 MoM and P-hCG >2.75 MoM in trisomy 21 detection. BMC Pregnancy Childbirth. 2023;23:363.
- Wang J, Li X, Chen Y et al. Multimarker approach (PAPP- A, free P-hCG, PIGF, AFP + NT) detection rates in 13,000 women. Prenat Diagn. 2023;43(4):473-80.
- Ranganathan A, Fresen J, Sarkar P. Association of low first-trimester pregnancy-associated plasma protein A with adverse pregnancy outcomes: an observational study. Obstet Gynecol Rep. 2016; 1 (1): 1-6. doi:10.15761/OGR.1000116
- Gonzalez-Gonzalez NL, Gonzalez Davila E, Castro A et al. Effect of pregestational diabetes mellitus on first-trimester placental characteristics: three-dimensional placental volume and power Doppler indices. Placenta. 2014;35(3):147-51. doi:10.1016/j.placenta.2014.01.002
- Guibourdenche J, Leguy MC, Pidoux G et al. Biochemical screening for fetal trisomy 21: pathophysiology of maternal serum markers and involvement of the placenta. Int J Mol Sci. 2023;24(8):7669. doi: 10.3390/ijms24087669
- Kirovakov Z, Flinkova N, Konova E. The impact of inherited thrombophilia on first trimester combined aneuploidy screening parameters. Acta Medica Bulgarica. 2024;51(4):22-27. doi:10.2478/AMB-2024-0073.
- Jensen TK, Andersen AN, Bjerregaard B et al. Maternal age and the risk of fetal aneuploidy: a nationwide cohort study in Denmark. Acta Obstet Gynecol Scand. 2023. doi:10.1111/aogs.14713
- Flristova I, Naseva E, Yunakova M. Fetal growth abnormalities in overweight and obese pregnant women: a study among Bulgarian pregnant women. Acta Medica Bulgarica. 2026;53(Suppl 1):6-14. doi:10.2478/AMB-2026-0001.
- Aiken CE, Smith GC, Best C. Assisted reproductive technology and the risk of birth defects: a systematic review and meta-analysis. JAMA Pediatr. 2016;170(9):890-7. doi:10.1001/jamapediatrics.2016.1011
- Tannir G, Boulet S, Jamieson DJ. Genetic risks and outcomes in assisted reproductive technologies. Fertil Steril. 2021 ;115(5): 1101-9. doi:10.1016/j.fertnstert.2021.01.017
- Omoy A. Prenatal origin of obesity and diabetes: an update. Reprod Toxicol. 2015;56:98-106. doi:10.1016/j.reprotox.2015.05.002
- Robinson DO, Flail B, Jacobs PA. Parental origin of extra chromosomes in trisomy 21 and its relationship to maternal age. Hum Genet. 2009;126(2):231-7. doi:10.1007/s00439-009-0703-0
- Khoshnood B, Loane M, de Vigan C, Dolk FI. Long-term trends in prevalence of Down syndrome in Europe. Prenat Diagn. 2011;31(5):487-94. doi:10.1002/pd.2725
- Zhu X, Li FI, Wang J et al. Association of nuchal translucency with chromosomal abnormalities in a large Chinese cohort. JAMA Netw Open. 2023;6(3):e231234. doi:10.1001/jamanetworkopen.2023.1234
- Antonova I, Ivanov D, Yaneva G, et al. Body mass index as a factor influencing oocyte competence and implantation potential - distribution and results in 4,882 women undergoing fertility treatment. Acta Medica Bulgarica. 2024;51(2):8-13. doi:10.2478/AMB-2024-0024.
- Souka AP, Snijders RJ, Novakov A et al. Deficient growth in fetuses with trisomy 21 at 11-13+6 weeks of gestation. Ultra-sound Obstet Gynecol. 2002; 19(2): 117-20. doi:10.1002/pd.643
- Liao AW, Snijders RJ, Geerts L et al. Fetal growth in chromosomally abnormal fetuses. Ultrasound Obstet Gynecol. 2000; 15(1 ):9-13. doi: 10.1046/j. 1469-0705.2000.00002.x
- Spencer K, Spencer CE, Power M et al. Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: three years’ prospective experience. BJOG. 2003;110(3):281-6. doi: 10.1046/j. 1471-0528.2003.02292.X
- Krantz DA, Flallahan TW, Orlandi F et al. First-trimester Down syndrome screening using dried blood biochemistry and nuchal translucency. Obstet Gynecol. 2000;96(2):207-13. doi: 10.1016/S0029-7844(00)00895-1
Language: English
Page range: 36 - 43
Submitted on: Oct 15, 2025
Accepted on: Jan 23, 2026
Published on: Jun 16, 2026
Published by: Medical University - Sofia
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2026 B. Ilkovska, B. K. Trifunova, F. Ilkovski, D. Gramatkovski, M. Avramovska, P. Avramovski, L. Todorovska, published by Medical University - Sofia
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.